KELOWNA, BC / ACCESS Newswire / January 30, 2025 / Lexaria Bioscience Corp. , (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to provide this annual letter from ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 ...

The radio queen went for a dip at Sydney 's Clovelly beach where she did laps in the tide pool. The 49-year-old showed off ...

KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX), a leader in drug delivery platforms with a market capitalization of $31.77 million, has announced significant advancements in its DehydraTECH ...

Another option, minus the injection Novo Nordisk also manufactures Rybelsus, which is an oral semaglutide tablet approved for the treatment of type 2 diabetes. Novo Nordisk is seeking FDA approval ...

These are the active substances in well-known brands like Ozempic and Wegovy. Semaglutide is available as injectables, oral tablets, and drops. Liraglutide comes in injection form and you can get ...

Let's take a closer look at each of these medications. Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient ...

Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.